New

Hydrogel-Based Drug Delivery System Market

2021

Hydrogel-Based Drug Delivery System Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Source (Natural, Synthetic, and Hybrid); Route of Administration (Subcutaneous, Ocular, Oral Cavity, Topical, and Other), and Geography

| Report Code: TIPRE00024309 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Hydrogel-Based Drug Delivery System Market 2028 By Source, Route of Administration, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Hydrogels are 3D networks of water-soluble polymers that are cross-linked. Hydrogels are produced from almost any water-soluble polymer, and these can have a range of chemical compositions and bulk physical characteristics. Moreover, hydrogels can be made in multiple physical shapes, like slabs, microparticles, nanoparticles, coatings, and films. Therefore, hydrogels are widely used in clinical practice and experimental medicine for several applications, including tissue engineering and regenerative medicine, diagnostics, cellular immobilization, biomolecule or cell separation, and barrier materials to govern biological adhesions. Traditional drug delivery methods are hindered by concerns such as systemic toxicity and repetitive dosage. Hydrogels provide convenient drug delivery carriers, ensuring that these disadvantages are reduced while the drug's therapeutic benefits are enhanced. Hydrogels have emerged as highly efficient drug delivery systems due to delicately adjustable physical characteristics that provide controlled drug release features and the benefits of labile drug protection from degradation.

MARKET SCOPE

The "Global Hydrogel-Based Drug Delivery System Market Analysis to 2028" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Hydrogel-based drug delivery system market with detailed market segmentation by source, route of administration, and geography. The report provides key statistics on the market status of the leading Hydrogel-based drug delivery system market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on source, the global Hydrogel-based drug delivery system market is segmented into natural, synthetic, hybrid.
  •  On the basis of route of administration, the market is segmented into subcutaneous, ocular, oral cavity, topical, other.

MARKET DYNAMICS
Drivers:

  •  Increasing investment and funding by leading pharma companies in R&D activities in search of a new drug, delivery systems, and diagnostic.
  •  Rise in the demand for controlled release drug delivery system.
  •  Growth in the R&D efforts related to drug delivery systems.

Restraints:

  •  The complexity to produce hydrogel is the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Hydrogel-based drug delivery system market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Hydrogel-based drug delivery system market in these regions.

IMPACT OF COVID-19ON HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Hydrogel-based drug delivery system market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Hydrogel-based drug delivery system market are anticipated to lucrative growth opportunities in the future with the rising demand for Hydrogel-based drug delivery system in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Hydrogel-based drug delivery system market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  GlaxoSmithKline
  •  Alliance Pharmaceuticals Limited
  •  Oraldent Ltd.
  •  Ashland
  •  Johnson & Johnson
  •  Pfizer, Inc.
  •  Gilead Sciences
  •  Teva Pharmaceutical Industries Ltd.
  •  Valeant Pharmaceuticals International, Inc.
  •  Ferring B.V.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hydrogel-Based Drug Delivery System Market - By Source
1.3.2 Hydrogel-Based Drug Delivery System Market - By Route of Administration
1.3.3 Hydrogel-Based Drug Delivery System Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET - GLOBAL MARKET ANALYSIS
6.1. HYDROGEL-BASED DRUG DELIVERY SYSTEM - GLOBAL MARKET OVERVIEW
6.2. HYDROGEL-BASED DRUG DELIVERY SYSTEM - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET - REVENUE AND FORECASTS TO 2028 - SOURCE
7.1. OVERVIEW
7.2. SOURCE MARKET FORECASTS AND ANALYSIS
7.3. NATURAL
7.3.1. Overview
7.3.2. Natural Market Forecast and Analysis
7.4. SYNTHETIC
7.4.1. Overview
7.4.2. Synthetic Market Forecast and Analysis
7.5. HYBRID
7.5.1. Overview
7.5.2. Hybrid Market Forecast and Analysis
8. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. SUBCUTANEOUS
8.3.1. Overview
8.3.2. Subcutaneous Market Forecast and Analysis
8.4. OCULAR
8.4.1. Overview
8.4.2. Ocular Market Forecast and Analysis
8.5. ORAL CAVITY
8.5.1. Overview
8.5.2. Oral Cavity Market Forecast and Analysis
8.6. TOPICAL
8.6.1. Overview
8.6.2. Topical Market Forecast and Analysis
8.7. OTHER
8.7.1. Overview
8.7.2. Other Market Forecast and Analysis
9. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Hydrogel-Based Drug Delivery System Market Overview
9.1.2 North America Hydrogel-Based Drug Delivery System Market Forecasts and Analysis
9.1.3 North America Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Source
9.1.4 North America Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Route of Administration
9.1.5 North America Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Countries
9.1.5.1 United States Hydrogel-Based Drug Delivery System Market
9.1.5.1.1 United States Hydrogel-Based Drug Delivery System Market by Source
9.1.5.1.2 United States Hydrogel-Based Drug Delivery System Market by Route of Administration
9.1.5.2 Canada Hydrogel-Based Drug Delivery System Market
9.1.5.2.1 Canada Hydrogel-Based Drug Delivery System Market by Source
9.1.5.2.2 Canada Hydrogel-Based Drug Delivery System Market by Route of Administration
9.1.5.3 Mexico Hydrogel-Based Drug Delivery System Market
9.1.5.3.1 Mexico Hydrogel-Based Drug Delivery System Market by Source
9.1.5.3.2 Mexico Hydrogel-Based Drug Delivery System Market by Route of Administration
9.2. EUROPE
9.2.1 Europe Hydrogel-Based Drug Delivery System Market Overview
9.2.2 Europe Hydrogel-Based Drug Delivery System Market Forecasts and Analysis
9.2.3 Europe Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Source
9.2.4 Europe Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Route of Administration
9.2.5 Europe Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Hydrogel-Based Drug Delivery System Market
9.2.5.1.1 Germany Hydrogel-Based Drug Delivery System Market by Source
9.2.5.1.2 Germany Hydrogel-Based Drug Delivery System Market by Route of Administration
9.2.5.2 France Hydrogel-Based Drug Delivery System Market
9.2.5.2.1 France Hydrogel-Based Drug Delivery System Market by Source
9.2.5.2.2 France Hydrogel-Based Drug Delivery System Market by Route of Administration
9.2.5.3 Spain Hydrogel-Based Drug Delivery System Market
9.2.5.3.1 Spain Hydrogel-Based Drug Delivery System Market by Source
9.2.5.3.2 Spain Hydrogel-Based Drug Delivery System Market by Route of Administration
9.2.5.4 United Kingdom Hydrogel-Based Drug Delivery System Market
9.2.5.4.1 United Kingdom Hydrogel-Based Drug Delivery System Market by Source
9.2.5.4.2 United Kingdom Hydrogel-Based Drug Delivery System Market by Route of Administration
9.2.5.5 Rest of Europe Hydrogel-Based Drug Delivery System Market
9.2.5.5.1 Rest of Europe Hydrogel-Based Drug Delivery System Market by Source
9.2.5.5.2 Rest of Europe Hydrogel-Based Drug Delivery System Market by Route of Administration
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Hydrogel-Based Drug Delivery System Market Overview
9.3.2 Asia-Pacific Hydrogel-Based Drug Delivery System Market Forecasts and Analysis
9.3.3 Asia-Pacific Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Source
9.3.4 Asia-Pacific Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Route of Administration
9.3.5 Asia-Pacific Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Hydrogel-Based Drug Delivery System Market
9.3.5.1.1 Australia Hydrogel-Based Drug Delivery System Market by Source
9.3.5.1.2 Australia Hydrogel-Based Drug Delivery System Market by Route of Administration
9.3.5.2 China Hydrogel-Based Drug Delivery System Market
9.3.5.2.1 China Hydrogel-Based Drug Delivery System Market by Source
9.3.5.2.2 China Hydrogel-Based Drug Delivery System Market by Route of Administration
9.3.5.3 India Hydrogel-Based Drug Delivery System Market
9.3.5.3.1 India Hydrogel-Based Drug Delivery System Market by Source
9.3.5.3.2 India Hydrogel-Based Drug Delivery System Market by Route of Administration
9.3.5.4 Japan Hydrogel-Based Drug Delivery System Market
9.3.5.4.1 Japan Hydrogel-Based Drug Delivery System Market by Source
9.3.5.4.2 Japan Hydrogel-Based Drug Delivery System Market by Route of Administration
9.3.5.5 South Korea Hydrogel-Based Drug Delivery System Market
9.3.5.5.1 South Korea Hydrogel-Based Drug Delivery System Market by Source
9.3.5.5.2 South Korea Hydrogel-Based Drug Delivery System Market by Route of Administration
9.3.5.6 Rest of Asia-Pacific Hydrogel-Based Drug Delivery System Market
9.3.5.6.1 Rest of Asia-Pacific Hydrogel-Based Drug Delivery System Market by Source
9.3.5.6.2 Rest of Asia-Pacific Hydrogel-Based Drug Delivery System Market by Route of Administration
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Hydrogel-Based Drug Delivery System Market Overview
9.4.2 Middle East and Africa Hydrogel-Based Drug Delivery System Market Forecasts and Analysis
9.4.3 Middle East and Africa Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Source
9.4.4 Middle East and Africa Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Route of Administration
9.4.5 Middle East and Africa Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Hydrogel-Based Drug Delivery System Market
9.4.5.1.1 South Africa Hydrogel-Based Drug Delivery System Market by Source
9.4.5.1.2 South Africa Hydrogel-Based Drug Delivery System Market by Route of Administration
9.4.5.2 Saudi Arabia Hydrogel-Based Drug Delivery System Market
9.4.5.2.1 Saudi Arabia Hydrogel-Based Drug Delivery System Market by Source
9.4.5.2.2 Saudi Arabia Hydrogel-Based Drug Delivery System Market by Route of Administration
9.4.5.3 U.A.E Hydrogel-Based Drug Delivery System Market
9.4.5.3.1 U.A.E Hydrogel-Based Drug Delivery System Market by Source
9.4.5.3.2 U.A.E Hydrogel-Based Drug Delivery System Market by Route of Administration
9.4.5.4 Rest of Middle East and Africa Hydrogel-Based Drug Delivery System Market
9.4.5.4.1 Rest of Middle East and Africa Hydrogel-Based Drug Delivery System Market by Source
9.4.5.4.2 Rest of Middle East and Africa Hydrogel-Based Drug Delivery System Market by Route of Administration
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Hydrogel-Based Drug Delivery System Market Overview
9.5.2 South and Central America Hydrogel-Based Drug Delivery System Market Forecasts and Analysis
9.5.3 South and Central America Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Source
9.5.4 South and Central America Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Route of Administration
9.5.5 South and Central America Hydrogel-Based Drug Delivery System Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Hydrogel-Based Drug Delivery System Market
9.5.5.1.1 Brazil Hydrogel-Based Drug Delivery System Market by Source
9.5.5.1.2 Brazil Hydrogel-Based Drug Delivery System Market by Route of Administration
9.5.5.2 Argentina Hydrogel-Based Drug Delivery System Market
9.5.5.2.1 Argentina Hydrogel-Based Drug Delivery System Market by Source
9.5.5.2.2 Argentina Hydrogel-Based Drug Delivery System Market by Route of Administration
9.5.5.3 Rest of South and Central America Hydrogel-Based Drug Delivery System Market
9.5.5.3.1 Rest of South and Central America Hydrogel-Based Drug Delivery System Market by Source
9.5.5.3.2 Rest of South and Central America Hydrogel-Based Drug Delivery System Market by Route of Administration
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLIANCE PHARMACEUTICALS LIMITED
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ORALDENT LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ASHLAND
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JOHNSON AND JOHNSON
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PFIZER, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GILEAD SCIENCES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. FERRING B.V.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. GlaxoSmithKline
2. Alliance Pharmaceuticals Limited
3. Oraldent Ltd.
4. Ashland
5. Johnson & Johnson
6. Pfizer, Inc.
7. Gilead Sciences
8. Teva Pharmaceutical Industries Ltd.
9. Valeant Pharmaceuticals International, Inc.
10. Ferring B.V.
11. Endo International plc
12. Akorn, Incorporated
13. Tolmar Pharmaceuticals, Inc.
14. GALDERMA
15. Blairex Laboratories, Inc.
16. Bausch and Lomb
17. Medtronic
18. Ocular Therapeutix, Inc.
TIPRE00024309
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.